paediatrics Brussels 17

Epidemiology

• While HL represents only

approximately

4–5%

of all

cancers in children

< 15 y.

•

16%

in the adolescent,

making HL the most

common malignancy

within this age group

(15–19 years old)

Bleyer, W.A., O

’

Leary, M., Barr, R. & Ries, L.A.G. (eds) (2006) National Cancer

Institute, NIH Pub. No. 06-5767 Bethesda, MD